Press Room

There are 4 item(s) tagged with the keyword "artificial pancreas".

1. Defymed Receives Support from JDRF to Fight Type 1 Diabetes

JDRF will contribute up to $500,000 in funds to finance preclinical studies on the MAILPAN® bioartificial pancreas


2. Sansum Diabetes Research Institute, University of California, Santa Barbara Conduct Innovative Artificial Pancreas – Ultra-Rapid-Acting Inhaled Insulin Trial Funded by JDRF

JDRF, Sansum Diabetes Research Institute, and the College of Engineering at University of California, Santa Barbara (UCSB) are pleased to announce the first successful clinical research trial using the artificial pancreas in conjunction with ultra-rapid-acting inhaled insulin. 


3. JDRF Applauds Launch of New Low Glucose Suspend Technology

 JDRF, the leading global organization funding type 1 diabetes (T1D) research, today applauded the U.S. Food and Drug Administration (FDA) for its commitment to ensuring patients in the United States can access insulin pumps that can temporarily stop insulin delivery once sensor glucose levels ...


4. Tom Brobson: My AP Trial Experience

Tom Brobson, National Director, Research Investment Opportunities, relates his personal experience participating in a recent, real world trial of the artificial pancreas system.


Lets turn type one into type none